Back to Browse Journals » Clinical Interventions in Aging » Volume 2 » Issue 3

Predictors of adherence to physical activity in the Lifestyle Interventions and Independence for Elders pilot study (LIFE-P)

Authors W Jack Rejeski, Michael E Miller, Abby C King, Stephanie A Studenski, Jeffrey A Katula, et al For the LIFE Investigators (2006)

Published 15 October 2007 Volume 2007:2(3) Pages 485—494

W Jack Rejeski1, Michael E Miller2, Abby C King3, Stephanie A Studenski4, Jeffrey A Katula1, Roger A Fielding5, Nancy W Glynn4, Michael P Walkup2, Jamile A Ashmore6, For the LIFE Investigators (2006)

1Department of Health and Exercise Science, Wake Forest University; 2Department of Biostatistics, Wake Forest University; 3Stanford University; 4University of Pittsburgh; 5Tuffs University; 6Cooper Institute

Objectives: A prospective design was used to examine predictors of adherence to a physical activity intervention in older adults with compromised function.

Methods: The sample included 213 men (31.1%) and women (68.9%) with an average age of 76.53 years.

Results: The predictor variables accounted for 10% of the variance in percent attendance during adoption and transition, respectively. Adding percent attendance during adoption to the prediction of percent attendance during transition increased the explained variance in this phase to 21%. During maintenance, the predictors accounted for 13% of the variance in frequency of physical activity; this estimate increased to 46% when adding in percent attendance from the transition phase.

Discussion: These results are encouraging in that the physical activity intervention appears to have been well tolerated by diverse subgroups of older adults. The role of prior behavior in predicting downstream adherence underscores the importance of developing proactive interventions for treating nonadherence in older adult populations.

Keywords: Disability, Physical Activity, Older Adults, Adherence

Download Article [PDF] 

Readers of this article also read:

JC virus antibody index in natalizumab-treated patients: correlations with John Cunningham virus DNA and C-reactive protein level

Lanzillo R, Liuzzi R, Vallefuoco L, Moccia M, Amato L, Vacca G, Vacchiano V, Portella G, Brescia Morra V

Therapeutics and Clinical Risk Management 2014, 10:807-814

Published Date: 9 October 2014

Cutaneous factitia in elderly patients: alarm signal for psychiatric disorders

Chiriac A, Foia L, Birsan C, Goriuc A, Solovan C

Clinical Interventions in Aging 2014, 9:421-424

Published Date: 12 March 2014

A functional polymorphism in the epidermal growth factor gene predicts hepatocellular carcinoma risk in Japanese hepatitis C patients

Suenaga M, Yamada S, Fujii T, Fuchs BC, Okumura N, Kanda M, Kobayashi D, Tanaka C, Nakayama G, Sugimoto H, Koike M, Nomoto S, Fujiwara M, Takeda S, Hayashi K, Tanabe KK, Goto H, Kodera Y

OncoTargets and Therapy 2013, 6:1805-1812

Published Date: 13 December 2013

Hypersomnia in children affected by migraine without aura: a questionnaire-based case-control study

Esposito M, Roccella M, Parisi L, Gallai B, Carotenuto M

Neuropsychiatric Disease and Treatment 2013, 9:289-294

Published Date: 21 February 2013

The influence of selective vitamin D receptor activator paricalcitol on cardiovascular system and cardiorenal protection

Duplancic D, Cesarik M, Poljak NK, Radman M, Kovacic V, Radic J, Rogosic V

Clinical Interventions in Aging 2013, 8:149-156

Published Date: 11 February 2013

Behavioral interactions of simvastatin and fluoxetine in tests of anxiety and depression

Santos T, Baungratz MM, Haskel SP, de Lima DD, da Cruz JN, Dal Magro DD, da Cruz JG

Neuropsychiatric Disease and Treatment 2012, 8:413-422

Published Date: 1 October 2012

Characterization of drug-release kinetics in trabecular bone from titania nanotube implants

Aw MS, Khalid KA, Gulati K, Atkins GJ, Pivonka P, Findlay DM, Losic D

International Journal of Nanomedicine 2012, 7:4883-4892

Published Date: 12 September 2012

Fludarabine in the treatment of chronic lymphocytic leukemia: a review

Francesca Ricci, Alessandra Tedeschi, Enrica Morra, Marco Montillo

Therapeutics and Clinical Risk Management 2009, 5:187-207

Published Date: 4 March 2009